Professor Philip Helliwell
- Position: Professor (Clinical Rheumatology)
- Areas of expertise: Psoriatic arthritis epidemiology; outcomes and clinical phenotypes of psoriatic arthritis; foot disorders in rheumatic diseases
- Email: P.Helliwell@leeds.ac.uk
- Phone: +44(0)113 392 3064
- Location: 08/0C/017B Chapel Allerton Hospital
My main responsibilities are clinical studies in psoriatic arthritis and foot disorders. I am Professor of Clinical Rheumatology at the University of Leeds and Honorary Consultant Rheumatologist for the Bradford Hospitals NHS Trust.
Previous and current appointments include
Member of NHS R&D Research Committee on Physical and Complex Disabilities
Member of the Executive Council
Centre for Biomechanics and Medical Engineering
Treasurer and Member of Executive Committee
Society for Back Pain Research
Member of Education Committee
Arthritis Research Campaign
Editor for the ARC Patient Information Leaflets
Convener Publications Working Group
Member of the Heberden Committee at the British Society for Rheumatology
Member of Council at the British Society for Rheumatology.
Professor Helliwell is a member of ASAS (Assessment of Spondyloarthropathy Society) and co-founder and Vice President of the Group for Research and Assessment of Psoriasis and Psoriatic arthritis (GRAPPA) developing single and composite outcome measures in psoriatic arthritis.
Professor Helliwell is a rheumatologist and researcher with a primary interest in psoriatic arthritis but also a strong research portfolio concerning the foot and ankle. My research covers two main areas: psoriatic arthritis and the foot and ankle, with a combination of clinical research and laboratory (biomechanical) science. My major research interest is in accurate phenotyping of psoriatic arthritis, and personalising treatment response according to phenotype. Outcome measure development and validation continue to be a strong element in my research portfolio.
I am co-founder and immediate past President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and co-founder of the FASTER group at the University of Leeds
I have worked in this field for over 30 years and has contributed substantially to knowledge of the clinical manifestations of psoriatic arthritis, classification criteria, outcome measurement, and treatment strategies. I have been chief investigator on two major international collaborative studies and chief investigator for the first strategy trial in psoriatic arthritis. I have developed a number of outcome tools for use in rheumatology, notable the Psoriasis Epidemiology Screening Tool, the Leeds Dactylitis Instrument, the Leeds Enthesitis Instrument, and the Psoriatic Arthritis Disease Activity Score.
To access PDF downloads relating to my work and research on outcome measures for spondyloarthritis and foot disorders, please visit the following link: https://medicinehealth.leeds.ac.uk/downloads/download/75/outcome_measures_for_spondyloarthritis_and_foot_disorders
- BM BCh
My clinical duties span two major teaching hospital trusts (Leeds and Bradford) and I am co-founder of the Bradford Diploma in Rheumatology and Musculoskeletal Medicine.
Research groups and institutes
- Leeds Institute of Rheumatic and Musculoskeletal Medicine
- Immunity and inflammation
- Musculoskeletal disease
- Dermato-Rheumatology Group